Amundi Purchases 100,740 Shares of STERIS plc (NYSE:STE)

Amundi increased its holdings in shares of STERIS plc (NYSE:STE) by 28.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 459,066 shares of the medical equipment provider’s stock after buying an additional 100,740 shares during the quarter. Amundi owned 0.47% of STERIS worth $96,142,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Ashton Thomas Securities LLC acquired a new stake in shares of STERIS during the third quarter worth about $25,000. Human Investing LLC bought a new stake in STERIS during the 4th quarter worth approximately $31,000. Anfield Capital Management LLC raised its holdings in STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division lifted its stake in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC boosted its holdings in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares during the period. 94.69% of the stock is currently owned by institutional investors.

STERIS Stock Down 0.5 %

STERIS stock opened at $231.49 on Tuesday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a fifty day simple moving average of $217.49 and a 200 day simple moving average of $222.68. The company has a market cap of $22.74 billion, a P/E ratio of 49.15 and a beta of 0.92.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be paid a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

Analyst Ratings Changes

STE has been the topic of a number of research analyst reports. Piper Sandler raised their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Stephens reissued an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.